Meeting
2024 ASCO Quality Care Symposium
Opioid tapering and discontinuation for head and neck cancer (HNC) survivors.
Authors
Talya Salz
Memorial Sloan Kettering Cancer Center, New York, NY
Talya Salz , Akriti Mishra Meza , Natalie Moryl , Anuja Kriplani , Kathryn Ries Tringale , James Flory , Patrick T Bradshaw , Sankeerth Jinna , Allison Lipitz-Snyderman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Survivorship
Sub Track
Late- and Long-Term Effects/Comorbidities
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 366)
DOI
10.1200/OP.2024.20.10_suppl.366
Abstract #
366
Poster Bd #
H22
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Persistent high-risk opioid use in lymphoma survivors following treatment.
First Author: Katherine Ann Stafford
Poster
2021 ASCO Quality Care Symposium
Sociodemographic differences in patient-reported pain and pain management of head and neck cancer patients in a community oncology setting.
First Author: Nosayaba Osazuwa-Peters
Poster
2018 Palliative and Supportive Care in Oncology Symposium
Opioid dose reduction and pain control with medical cannabis.
First Author: Ajaz Bulbul
Poster
2018 Cancer Survivorship Symposium
Successful use of buprenorphine/naloxone to treat opioid addiction after cancer therapy.
First Author: Natalie Moryl